US2010324267A1PendingUtilityA1
Novel traf family proteins
Assignee: BURNHAM INST MEDICAL RESEARCHPriority: Nov 5, 1999Filed: Dec 18, 2009Published: Dec 23, 2010
Est. expiryNov 5, 2019(expired)· nominal 20-yr term from priority
C07K 16/18
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
In accordance with the present invention, there are provided novel TRAF-Protein-Binding-Domain polypeptides (TPBDs). The invention also provides nucleic acid molecules encoding TPBDs, vectors containing these nucleic acid molecules and host cells containing the vectors. The invention also provides antibodies that can specifically bind to invention TPBDs. Such TPBDs and/or anti-TPBD antibodies are useful for discovery of drugs that suppress autoimmunity, inflammation, allergy, allograph rejection, sepsis, and other diseases.
Claims
exact text as granted — not AI-modified1 . A TRAF-Protein-Binding-Domain (TPBD) polypeptide comprising SEQ ID NO:19, provided said polypeptide is no longer than 213 amino acids.
2 . The TPBD polypeptide of claim 1 , further comprising SEQ ID NO:20.
3 . The TPBD polypeptide of claim 1 , further comprising SEQ ID NO:21.
4 . The TPBD of claim 1 , wherein the amino acid sequence of said protein comprises substantially the same sequence as any of SEQ ID NOS:8, 10, 12, 23, 24 or 25.
5 . The TPBD of claim 1 , comprising the same amino acid sequence as set forth in any of SEQ ID NOS:8, 10, 12, 23, 24 or 25.
6 . A TPBD according to claim 4 , wherein said polypeptide is encoded by a nucleotide sequence comprising substantially the same nucleotide sequence as set forth in SEQ ID NOs:7, 9 or 11.
7 . A TPBD according to claim 1 , wherein said polypeptide is encoded by a nucleotide sequence comprising the same sequence as set forth in SEQ ID NOs:7, 9 or 11.
8 - 11 . (canceled)
12 . Isolated nucleic acid encoding a TRAF protein binding domain (TPBD), or functional fragments thereof, selected from:
(a) DNA encoding the amino acid sequence set forth in SEQ ID NOS:8, 10 or 12, 23, 24 or 25, or (b) DNA that hybridizes to the DNA of (a) under moderately stringent conditions, wherein said DNA encodes biologically active TPBD, or (c) DNA degenerate with (b), wherein said DNA encodes biologically active TPBD.
13 . A nucleic acid according to claim 12 , wherein said nucleic acid hybridizes under high stringency conditions to the TPBD coding portion of any of SEQ ID NOs:7, 9 and 11.
14 . A nucleic acid according to claim 12 , wherein the nucleotide sequence of said nucleic acid is substantially the same as set forth in any of SEQ ID NO:7, 9 and 11.
15 - 50 . (canceled)
51 . A chimeric protein comprising the TPBD of claim 1 .
52 . A chimeric TPBD-containing protein, comprising the sequence SEQ ID NO:19, provided said chimeric protein is not naturally occurring.
53 . The chimeric TPBD-containing protein of claim 52 , comprising:
(a) the sequence SEQ ID NO:19; and (b) a sequence from a heterologous protein.
54 . The chimeric TPBD-containing protein of claim 53 , further comprising SEQ ID NO:20.
55 . The chimeric TPBD-containing protein of claim 53 , further comprising SEQ ID NO:21.
56 . The chimeric protein of claim 53 further comprising a RING finger domain.
57 . An isolated TPBD-containing TRAF protein, or fragment thereof, comprising the sequence SEQ ID NO:19, provided said TRAF domain containing protein does not consist of the sequence SEQ ID NOs:2, 4 or 6.
58 . The TPBD-containing TRAF protein of claim 57 , further comprising the sequence SEQ ID NO:20.
59 . The TPBD-containing TRAF protein of claim 57 , further comprising the sequence SEQ ID NO:21.
60 - 73 . (canceled)Join the waitlist — get patent alerts
Track US2010324267A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.